REMSEQ Trademark

Trademark Overview

On Thursday, November 14, 2019, a trademark application was filed for REMSEQ with the United States Patent and Trademark Office. The USPTO has given the REMSEQ trademark a serial number of 88692773. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 6, 2023. This trademark is owned by Remix Therapeutics Inc.. The REMSEQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical and therapeutic preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders

pharmaceutical, medical, scientific, and biopharmaceutical research and development
remseq

General Information

Serial Number88692773
Word MarkREMSEQ
Filing DateThursday, November 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements

Goods and Servicespharmaceutical and therapeutic preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
Goods and Servicespharmaceutical, medical, scientific, and biopharmaceutical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 10, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRemix Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRemix Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Thursday, November 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 7, 2020ASSIGNED TO EXAMINER
Thursday, January 9, 2020NON-FINAL ACTION WRITTEN
Thursday, January 9, 2020NON-FINAL ACTION WRITTEN
Thursday, January 9, 2020NON-FINAL ACTION WRITTEN
Thursday, January 9, 2020NON-FINAL ACTION E-MAILED
Thursday, January 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Tuesday, October 6, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 6, 2021SOU EXTENSION 1 GRANTED
Tuesday, April 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 6, 2021SOU EXTENSION 1 FILED
Thursday, April 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 29, 2021SOU EXTENSION 2 FILED
Wednesday, September 29, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 29, 2021SOU EXTENSION 2 GRANTED
Tuesday, April 5, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 5, 2022SOU EXTENSION 3 FILED
Tuesday, April 5, 2022SOU EXTENSION 3 GRANTED
Friday, October 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 4, 2022SOU EXTENSION 4 FILED
Tuesday, October 4, 2022SOU EXTENSION 4 GRANTED
Thursday, October 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 6, 2023SOU EXTENSION 5 FILED
Thursday, April 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 13, 2023SOU EXTENSION 5 GRANTED
Friday, April 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, November 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

remseq disorders diseases pharmaceutical medical neurological scientific biopharmaceutical development research genetic